{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:30:42Z","timestamp":1787805042116,"version":"build-2784847793"},"reference-count":31,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Dermatology"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Interleukin (IL)\u20102 stimulates antitumour immunity and is successfully used for the treatment of different neoplasias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis\/Objectives<\/jats:title>\n                    <jats:p>Canarypox virus locally expressing feline IL\u20102 is safe and can be used to treat equine sarcoids.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Twenty horses of different breeds with a median age of eight years (interquartile range 6.0\u201313.3 years) and a total number of 59 sarcoids were included in the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective clinical trial, sarcoids were injected twice seven days apart, with a recombinant canarypox virus expressing feline IL\u20102. Complete blood counts (CBC) and fibrinogen levels were measured before treatment and on days 1, 2, 7 and 8.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Complete regression was achieved in eight horses (40%) and partial regression in two horses (10%). No change in sarcoid size was observed in two horses (10%) and the disease progressed in five horses (25%). Sarcoids of three horses (15%) showed initial response followed by tumour growth. There were no significant changes in CBC and fibrinogen levels after either injection. One horse developed a mild fever the day after each injection, which subsided without treatment the following day.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Treatment of equine sarcoids with recombinant canarypox virus expressing feline IL\u20102 seems to be a safe therapy option. Although the expression of IL\u20102 after vector injection and its biological activity in horses were not proven in this study, the treatment resulted in regression and partial regression in 50% of the cases. Further studies are necessary to verify these findings and to establish a treatment protocol.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/vde.12941","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T02:37:17Z","timestamp":1615948637000},"page":"283","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Treatment of equine sarcoids using recombinant poxviruses expressing feline interleukin\u20102"],"prefix":"10.1111","volume":"32","author":[{"given":"Johanna","family":"Loschelder\u2010Ostrowski","sequence":"first","affiliation":[{"name":"Clinic for Horses Free University of Berlin Oertzenweg 19b Berlin 14163 Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1849-9095","authenticated-orcid":false,"given":"Judith Christine","family":"Winter","sequence":"additional","affiliation":[{"name":"Clinic for Horses Free University of Berlin Oertzenweg 19b Berlin 14163 Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roswitha","family":"Merle","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Free University of Berlin K\u00f6nigsweg 67 Berlin 14163 Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Klopfleisch","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathology Free University of Berlin Robert\u2010von\u2010Ostertag\u2010Str. 15 Berlin 14163 Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidrun","family":"Gehlen","sequence":"additional","affiliation":[{"name":"Clinic for Horses Free University of Berlin Oertzenweg 19b Berlin 14163 Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,3,16]]},"reference":[{"key":"e_1_2_5_2_1","first-page":"378","article-title":"The incidence and pathology of tumours of domesticated animals in South Africa: a study of the Onderstepoort collection of neoplasms, with special reference to histopathology","volume":"6","author":"Jackson C","year":"1936","journal-title":"Onderstepoort J Vet Sci"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-0739(17)30189-X"},{"key":"e_1_2_5_4_1","first-page":"3,367","article-title":"Equine sarcoid tumour treated by autogenous tumour vaccine","volume":"19","author":"Kinnunen RE","year":"1998","journal-title":"Anticancer Res"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00199861"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/vr.149.22.665"},{"key":"e_1_2_5_7_1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2460\/javma.1993.202.02.261","article-title":"Intratumoral chemotherapy with cisplatin in oily emulsion in horses","volume":"202","author":"Theon AP","year":"1993","journal-title":"J Am Vet Med Assoc"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-3306.1988.tb01571.x"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1163462"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-002-0369-0"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198512053132327"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.4.661"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf105"},{"key":"e_1_2_5_14_1","first-page":"157","article-title":"Outpatient subcutaneous interleukin\u20102 and interferon\u2010alpha for metastatic renal cell cancer: five\u2010year follow\u2010up of the Cytokine Working Group Study","volume":"3","author":"Dutcher JP","year":"1997","journal-title":"Cancer J Sci Am"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.206"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00916947"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21596"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2005.16.91"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302124"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trivac.2014.11.001"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/vco.12032"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.11.066"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2427(95)05422-3"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.2460\/javma.249.3.311"},{"key":"e_1_2_5_25_1","first-page":"385","article-title":"The therapy of equine sarcoid with a non\u2010specific immunostimulator\u2013the epidemiology and spontaneous regression of sarcoids","volume":"139","author":"Studer U","year":"1996","journal-title":"Schweiz Arch Tierheilkd"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1264261"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-017-1215-0"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/01652176.2016.1204483"},{"key":"e_1_2_5_29_1","first-page":"679","article-title":"Tumour regression by IL\u20102 mediated stagnation of blood flow","volume":"5","author":"De HM","year":"1991","journal-title":"Vivo"},{"key":"e_1_2_5_30_1","first-page":"7,037","article-title":"Immunotherapy of mice with a large burden of disseminated lymphoma with low\u2010dose interleukin 2","volume":"49","author":"Maas RA","year":"1989","journal-title":"Cancer Res"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01788954"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01669425"}],"container-title":["Veterinary Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vde.12941","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/vde.12941","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vde.12941","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T23:33:27Z","timestamp":1724628807000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/vde.12941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,16]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.1111\/vde.12941"],"URL":"https:\/\/doi.org\/10.1111\/vde.12941","archive":["Portico"],"relation":{},"ISSN":["0959-4493","1365-3164"],"issn-type":[{"value":"0959-4493","type":"print"},{"value":"1365-3164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,16]]},"assertion":[{"value":"2019-05-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}